International, multicenter, prospective and observational registry. Percutaneous coronary intervention for treating de-novo lesions in small coronary vessels with Essential. Published in Coronary Artery Disease, 29(6):477-481, September 2018.
DESCRIPTION
Device
Essential
Number of patients
71
Follow up
12-month
Type of lesions
de – novo lesions in small coronary vessels
OUTCOMES
Primary endpoint
Target lesion failure (TLF)
Secondary endpoint
Global MACE
Rodés-Cabau J. Coronary Artery Disease. 29(6):477 481, September 2018
CONCLUSIONS
“These results show this treatment strategy may be a reliable alternative for small coronary vessels”
These data suggest the use of the Essential for treating de-novo coronary lesions in small coronary vessels was safe and associated with low rates of clinical events at the 12-month follow-up.
Published in Coronary Artery Disease, 29(6):477-481, September 2018.
MAIN INVESTIGATOR
Dr Josep Rodés-Cabau (PI)
Quebec Heart and Lung Institute (Quebec, CAN)
